Cha AI Healthcare Co., Ltd. (KRX:025620)
South Korea · Delayed Price · Currency is KRW 9,460.00
+570.00 (6.41%)
Last updated: Apr 8, 2026, 2:25 PM KST
Cha AI Healthcare Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 7,305 | 15,675 | 16,089 | 6,246 | 14,978 |
Other Revenue | - | -0 | - | -0 | -0 |
| 7,305 | 15,675 | 16,089 | 6,246 | 14,978 | |
Revenue Growth (YoY) | -53.40% | -2.57% | 157.58% | -58.30% | -50.92% |
Cost of Revenue | 5,241 | 8,324 | 8,123 | 5,342 | 14,261 |
Gross Profit | 2,064 | 7,351 | 7,966 | 904.53 | 716.44 |
Selling, General & Admin | 8,342 | 14,316 | 17,169 | 9,239 | 10,543 |
Other Operating Expenses | 23.44 | 53.6 | 192.19 | 86.36 | 115.14 |
Operating Expenses | 9,767 | 14,080 | 17,320 | 8,888 | 18,850 |
Operating Income | -7,702 | -6,728 | -9,354 | -7,983 | -18,133 |
Interest Expense | -1,083 | -122.87 | -109.53 | -484.8 | -1,737 |
Interest & Investment Income | 834.43 | 832.29 | 393.7 | 198.62 | 38.31 |
Earnings From Equity Investments | - | 316.92 | - | -4,593 | -9,456 |
Currency Exchange Gain (Loss) | -48.3 | 263.39 | 46.81 | 128.1 | 153.89 |
Other Non Operating Income (Expenses) | 12,449 | 777.59 | 741.27 | 1,923 | -165.97 |
EBT Excluding Unusual Items | 4,450 | -4,661 | -8,282 | -10,811 | -29,301 |
Impairment of Goodwill | - | - | - | - | -1,028 |
Gain (Loss) on Sale of Investments | -3,083 | -3,390 | 2,969 | -1,408 | 3,023 |
Gain (Loss) on Sale of Assets | 1 | -6.66 | -97.69 | 79.33 | -3.76 |
Asset Writedown | -0.47 | -225.97 | -545.88 | -7,371 | -8,618 |
Pretax Income | 1,367 | -8,283 | -5,957 | -19,511 | -35,927 |
Income Tax Expense | - | 1,519 | 10.22 | - | -42.1 |
Earnings From Continuing Operations | 1,367 | -9,802 | -5,967 | -19,511 | -35,885 |
Earnings From Discontinued Operations | - | 308.49 | -830.54 | -2,192 | -3,921 |
Net Income to Company | 1,367 | -9,493 | -6,798 | -21,703 | -39,805 |
Minority Interest in Earnings | 0 | 0.28 | 0.72 | 268.62 | 1,241 |
Net Income | 1,367 | -9,493 | -6,797 | -21,435 | -38,564 |
Net Income to Common | 1,367 | -9,493 | -6,797 | -21,435 | -38,564 |
Shares Outstanding (Basic) | 8 | 4 | 4 | 3 | 3 |
Shares Outstanding (Diluted) | 8 | 4 | 4 | 3 | 3 |
Shares Change (YoY) | 68.80% | 2.70% | 54.22% | -3.40% | 42.72% |
EPS (Basic) | 181.00 | -2122.00 | -1560.23 | -7588.09 | -13187.50 |
EPS (Diluted) | 181.00 | -2122.00 | -1560.23 | -7588.09 | -13187.50 |
Free Cash Flow | -6,712 | -7,128 | -9,947 | -5,901 | -3,732 |
Free Cash Flow Per Share | -888.79 | -1593.21 | -2283.42 | -2088.95 | -1276.25 |
Gross Margin | 28.26% | 46.90% | 49.51% | 14.48% | 4.78% |
Operating Margin | -105.44% | -42.92% | -58.14% | -127.81% | -121.07% |
Profit Margin | 18.71% | -60.56% | -42.24% | -343.16% | -257.48% |
Free Cash Flow Margin | -91.88% | -45.47% | -61.83% | -94.47% | -24.92% |
EBITDA | -6,947 | -6,161 | -8,794 | -7,031 | -16,390 |
EBITDA Margin | -95.10% | -39.30% | -54.66% | -112.56% | -109.43% |
D&A For EBITDA | 754.98 | 567.15 | 560.32 | 952.46 | 1,743 |
EBIT | -7,702 | -6,728 | -9,354 | -7,983 | -18,133 |
EBIT Margin | -105.44% | -42.92% | -58.14% | -127.81% | -121.07% |
Advertising Expenses | 477.54 | 4,567 | 5,186 | 1,279 | 775.41 |
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.